Spots Global Cancer Trial Database for Home Transfusion for HEME

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Home Transfusion for HEME

Official Title: A Home Transfusion Program for Patients With Advanced Hematologic Malignancies

Study ID: NCT05509439

Conditions

Hematologic Malignancy

Interventions

Home Transfusion Program Components

Study Description

Brief Summary: The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions

Detailed Description: This feasibility study will be used to assess the feasibility and acceptability of a hospice-embedded home transfusion program to patients with hematologic malignancies. All enrolled subjects will be patients cared for at Dana Farber Cancer Institute. This study is a single-arm study of 10 patients with advanced hematologic malignancies who have a limited life-expectancy of six months or fewer and are hospice eligible. 10 Caregivers of enrolled patients will also be invited to participate if interested. This research study involves completing questionnaires, a brief interview, blood draws, and blood transfusions when needed. Participants will be in the research study for up to six months. It is expected that about 20 people will take part in this research study.